The prescription-drug upstart got an upgrade from Wall Street.
The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.
GDRX earnings call for the period ending December 31, 2023.
An unimpressive quarter featuring weak guidance led investors to hit the sell button.
GDRX earnings call for the period ending September 30, 2023.
These outperformers are all trading under $10 per share - for now. After beating the S&P 500 year-to-date, analysts think these standout single-digit stocks all have room to keep running higher.
GDRX earnings call for the period ending June 30, 2023.
With newfound business momentum and consensus EPS that's been topped in five straight quarters, GDRX could deliver a report shareholders have been waiting for.
While the S&P 500 and Dow were relatively flat in Wednesday’s trading, there were some very bullish price surprises from some very popular stocks.
The company agreed to a plan that will use its prescription pricing to help CVS Caremark members.